Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sees Large Increase in Short Interest

Sunshine Biopharma, Inc. (NASDAQ:SBFM) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 370,900 shares, a growth of 66.8% from the September 15th total of 222,300 shares. Currently, 30.4% of the company’s stock are sold short. Based on an average daily volume of 162,900 shares, the short-interest ratio is currently 2.3 days.

Sunshine Biopharma Trading Up 0.3 %

Shares of SBFM stock traded up $0.01 during trading on Monday, hitting $2.98. The company’s stock had a trading volume of 4,297 shares, compared to its average volume of 126,915. The company has a market cap of $3.64 million, a PE ratio of -0.01 and a beta of 1.39. The business has a fifty day moving average of $2.80 and a 200-day moving average of $2.19. Sunshine Biopharma has a 52 week low of $2.42 and a 52 week high of $659.60.

Sunshine Biopharma (NASDAQ:SBFM) last announced its quarterly earnings data on Friday, August 16th. The company reported ($9.94) earnings per share (EPS) for the quarter. Sunshine Biopharma had a negative net margin of 12.07% and a negative return on equity of 16.09%. The business had revenue of $9.30 million during the quarter.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.